Back to Search
NITA SEIBEL, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1770662843Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD17161(DC)
Research & Publications (20)
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
PMID 18039957·Blood·2008
2-rct
Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943.
PMID 17334983·Cancer·2007
3-trial
Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
PMID 14752069·J Clin Oncol·2004
3-trial
A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
PMID 19255017·Pediatrics·2009
3-trial
Pharmacokinetics and safety of caspofungin in older infants and toddlers.
PMID 19114680·Antimicrob Agents Chemother·2009
3-trial
Treatment of acute lymphoblastic leukemia in children and adolescents: peaks and pitfalls.
PMID 19074113·Hematology Am Soc Hematol Educ Program·2008
6-review
Acute lymphoblastic leukemia: an historical perspective.
PMID 19074111·Hematology Am Soc Hematol Educ Program·2008
8-other
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].
PMID 18802149·J Clin Oncol·2008
4-observational
Phase 2 trial of recombinant tumor necrosis factor-alpha in combination with dactinomycin in children with recurrent Wilms tumor.
PMID 18600176·J Immunother·2008
3-trial
Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.
PMID 18000167·Blood·2008
3-trial
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report.
PMID 17668867·Pediatr Blood Cancer·2008
3-trial
A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study.
PMID 17668866·Pediatr Blood Cancer·2008
3-trial
Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing.
PMID 17638696·Antimicrob Agents Chemother·2007
8-other
Nuclear localization of enhanced green fluorescent protein homomultimers.
PMID 17586454·Anal Biochem·2007
7-preclinical
Obesity and outcome in pediatric acute lymphoblastic leukemia.
PMID 17513811·J Clin Oncol·2007
8-other
Concomitant Candida epiglottitis and disseminated Varicella zoster virus infection associated with acute lymphoblastic leukemia.
PMID 17114965·J Pediatr Hematol Oncol·2006
5-case
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.
PMID 16678903·J Infect·2006
3-trial
Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors: a report from the Children's Oncology Group.
PMID 16532433·Cancer·2006
3-trial
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.
PMID 16436720·Antimicrob Agents Chemother·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 111 MICHIGAN AVE NW
WASHINGTON, DC 20010 - Phone
- (202) 884-2140
Quick Facts
- NPI
- 1770662843
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile